Browse the evidence

Overfeeding healthy young men of normal body weight does not trigger significant energy-wasting mechanisms (like adaptive thermogenesis); instead, 85-90% of excess energy intake is deposited as body mass.

If you are a healthy young man, your body does not have a strong 'safety valve' to burn off excess calories. If you consistently eat 1000 calories more than you need, 85-90% of those extra calories will be stored as body mass. Do not rely on your body to naturally adjust its metabolism to prevent weight gain.

A one-year maintenance program following a 17-week weight loss intervention does not prevent or delay weight regain in severely obese patients compared to weight loss alone.

For severely obese individuals, adding a year of monthly maintenance sessions after a successful 17-week weight loss program (including a very-low-calorie diet) does not improve the likelihood of keeping the weight off compared to just doing the 17-week program. Focus on mastering the behavioral changes and dietary habits during the initial intensive phase, as extended professional contact did not provide additional benefit in this population.

In non-obese adult humans, circulating leptin levels do not predict or influence adaptive variations in energy expenditure (resting metabolic rate, thermic effect of feeding, or total energy expenditure).

For healthy, non-obese adults, your circulating leptin levels do not dictate your metabolic rate or how many calories you burn through activity. Focus on maintaining muscle mass and physical activity, as these are the primary drivers of energy expenditure, rather than trying to manipulate leptin levels directly.

Femoral subcutaneous adipose tissue exhibits significantly higher in vivo preadipocyte and adipocyte formation rates compared to abdominal subcutaneous tissue in women.

Your body's fat distribution is biologically determined. In women, thigh fat (femoral) tends to have higher cell turnover and expansion capacity than belly fat (abdominal). This is why lower-body fat is often considered more metabolically protective. You cannot change this genetic predisposition, but understanding it explains why fat accumulates differently in different areas.

In Mexican adults, general adiposity (BMI or height-adjusted weight) is a stronger independent predictor of blood pressure than central adiposity (waist circumference, waist-hip ratio, or waist-height ratio), with no evidence of threshold effects.

For Mexican adults, maintaining a healthy overall body weight is more critical for controlling blood pressure than focusing solely on waist size. Since there is no 'safe' threshold for adiposity, lower general body weight is consistently associated with lower blood pressure, regardless of where the fat is stored.

In obese women, body fat distribution (upper vs. lower body) does not significantly correlate with basal metabolic rate (BMR), sleeping metabolic rate (SMR), or 24-hour energy expenditure (24h-EE).

For obese women, where you carry your fat (waist vs. hips) does not appear to change your resting metabolic rate. Weight loss strategies should focus on caloric balance rather than targeting specific fat distribution areas for metabolic boost.

GLP-1R signaling primarily occurs through the Gαs/cAMP pathway, leading to insulin secretion, but also involves Gαq and β-arrestin pathways which contribute to receptor internalization and other metabolic effects.

GLP-1 drugs work by activating specific pathways in the body. The main pathway increases insulin when blood sugar is high. Other pathways help with receptor recycling and may contribute to other effects like cell survival.

Non-POMC neurons, specifically GABAergic neurons, mediate leptin's direct effects on energy balance and food intake, influencing POMC neurons indirectly.

This suggests that treatments targeting only POMC neurons may fail to reduce appetite. Future therapies might need to target GABAergic neurons or other non-POMC pathways to effectively manage obesity via leptin signaling.

POMC neurons expressing the glucagon-like peptide 1 receptor (Glp1r) are a distinct subpopulation from those expressing the leptin receptor (Lepr), and Glp1r-expressing POMC neurons may regulate energy balance.

This heterogeneity explains why broad activation of POMC neurons might have mixed results. Targeted therapies might need to distinguish between Lepr-expressing (glucose) and Glp1r-expressing (energy balance) subsets.

Metabolic surgery, which yields approximately 25% weight loss at 10 years, is associated with a 44% lower risk of invasive cancer compared to non-surgical patients.

For individuals with severe obesity, metabolic surgery can lead to significant weight loss and a substantially lower risk of invasive cancer. Discuss with your doctor if you are a candidate.

Visceral adipose tissue (VAT) is a stronger predictor of fasting insulin than total adiposity (BMI or percent fat) in young adults with normal glucose tolerance, except in lean black men.

For young adults with normal blood sugar, where you carry fat matters more for insulin health than how much you weigh. Measuring your waist circumference is a simple, effective way to assess metabolic risk, especially if you are white or female. However, for lean black men, standard adiposity measures may not accurately reflect insulin sensitivity, suggesting other factors or measurement limitations may be at play.

Chronic aerobic exercise training reverses high-fat diet-induced impairments in the compartmentalization and activation of insulin-signaling components (specifically aPKC and Akt2) in skeletal muscle, thereby restoring insulin-stimulated glucose transport.

If you have developed insulin resistance from a poor diet, consistent aerobic exercise (like brisk uphill walking or jogging) can restore your muscles' ability to respond to insulin. This happens by fixing how key signaling proteins move to the cell surface to let glucose in. Unlike some medications which may not fix these specific cellular defects, exercise directly corrects the machinery.

Overfeeding-induced insulin resistance is driven by the depletion of small, peripherally located intramyocellular lipid droplets and the subsequent accumulation of large lipid droplets and ceramides, rather than by an increase in total intramyocellular lipid content.

If you are concerned about insulin resistance, focus on maintaining physical activity levels that preserve small, peripheral muscle lipid droplets. High physical activity and efficient lipid oxidation are associated with resistance to weight gain and better insulin sensitivity, even during periods of overfeeding. The total amount of fat in your muscles matters less than how your body organizes that fat.

Increasing protein intake to 1.6 g/kg/day during resistance training does not enhance strength or lean body mass gains compared to moderate intake (1.0 g/kg/day) in previously untrained middle-aged adults.

If you are middle-aged and new to resistance training, you do not need to obsess over high protein intakes (1.6g/kg+). Getting your protein to around 1.0-1.2 g/kg of body weight is sufficient to maximize your strength and muscle gains. Focus on consistent training and hitting that moderate target rather than over-consuming protein, which offers no additional muscle-building benefit in this group.

Extending a behavioral weight loss maintenance intervention (monthly brief counseling) for an additional 30 months provides no significant additional benefit in preventing weight regain compared to stopping the intervention after 30 months.

If you have successfully maintained your weight loss for about 2.5 years through behavioral strategies (diet, exercise, self-monitoring), you may not need to pay for or commit to ongoing professional maintenance counseling. The data suggests that the 'maintenance mode' becomes easier over time, and stopping formal support does not necessarily lead to rapid regain for those who have already succeeded.

Supplementation with commercially available leucine metabolites (α-HICA, HMB-FA, or HMB-Ca) does not enhance resistance training-induced gains in muscle thickness, strength, or power in young, moderately trained men consuming a high-protein diet.

If you are a young, moderately trained man eating enough protein and training consistently, taking HMB or α-HICA will not give you better muscles or strength than if you just took a placebo. Focus on your training and diet instead of spending money on these supplements.

SGLT-2 inhibitors provide kidney protection (slowing eGFR decline, reducing albuminuria) but have limited or no impact on body weight, making them distinct from GLP-1s in treating obesity-related kidney disease.

SGLT-2 inhibitors protect the kidneys by slowing function decline and reducing protein in urine. They are not primarily weight-loss drugs, so they should be used alongside lifestyle changes for obesity.

Co-administration of the GLP-1 receptor agonist liraglutide and nicotine synergistically lowers body weight in obese mice by simultaneously reducing food intake and increasing energy expenditure.

In obese mice, combining a GLP-1 drug (liraglutide) with nicotine resulted in greater weight loss than either drug alone. This happened because the combination reduced hunger more effectively and increased the body's energy expenditure. This suggests that for humans, smokers might experience enhanced weight loss from GLP-1 medications, or that specific nicotine-targeting strategies could boost GLP-1 efficacy.

GLP-1 receptor agonism (liraglutide) sensitizes hypothalamic POMC neurons and ventral tegmental area (VTA) dopaminergic neurons to nicotine, increasing their excitability and contributing to weight loss.

GLP-1 drugs may work better for smokers because they make the brain's reward and hunger centers more responsive to nicotine. This interaction increases the activity of neurons that suppress appetite and burn energy.

Chronic supplementation with high-dose Vitamin C and E combined with strength training does not enhance muscle strength or hypertrophy and may blunt hypertrophic adaptations.

Do not take high-dose Vitamin C and E supplements if your goal is to build muscle or strength through resistance training. These supplements do not improve your gains and may actually stop your muscles from growing by blocking the natural chemical signals your body uses to adapt to exercise. Save your money and focus on your training and whole-food nutrition.

Receiving one's preferred diet (low-carbohydrate or low-fat) in a weight loss trial is associated with significantly less weight loss compared to not receiving the preferred diet or having no strong preference.

Do not choose a diet based on what you think you 'prefer' or what tastes best. This study found that people who got their preferred diet lost less weight than those who didn't. If you are flexible and willing to try different approaches, you may achieve better results than if you rigidly stick to a diet you prefer. Focus on adherence and caloric deficit rather than preference.

Acute systemic hypoglycemia gates and enhances the entry and action of GLP-1 receptor agonists into the brain, leading to increased whole-body lipid oxidation.

If you are using a GLP-1 medication, maintaining stable or slightly lower blood glucose levels (without dangerous hypoglycemia) may help the drug work more effectively in your brain to burn fat. The drug's ability to enter the brain and boost fat burning is significantly enhanced when blood sugar is low, a mechanism that is often impaired in obesity.

Obesity and high-fat diets uncouple the mechanism by which low blood glucose enhances GLP-1 receptor agonist entry into the brain.

If you are obese or eat a high-fat diet, the mechanism that helps GLP-1 drugs enter your brain to burn fat may be less effective. Managing blood glucose and reducing high-fat intake might help restore this natural gating mechanism.

Mechanical unloading, changes in adipokines (increased adiponectin, decreased leptin), and reduced estrogen levels are primary mechanisms driving bone loss during caloric restriction.

Understanding that bone loss is driven by hormonal and mechanical changes helps contextualize the risk. It is not necessarily 'damage' but an adaptation. Addressing it involves mimicking the mechanical load (exercise) and ensuring nutritional support (calcium/vitamin D) that the body might otherwise get from fat tissue.